	Low-grade phyllodes tumour of the prostate: an incidental diagnosis after lobe-selective holmium laser enucleation. BMJ Case Rep Mittal S, Rajendran R, Mathew G, Kalavampara V S. PMID: 42933849 [PubMed - in process]
	Advances in the management of renal cell carcinoma. BMJ Lewis AR, Lyon TD, Gupta S, Zakharia Y, Leibovich BC, Costello BA. PMID: 42933810 [PubMed - indexed for MEDLINE]
	Recommendations for the management of anemia in patients with cancer and chronic kidney disease: a position statement from the American Society of Onconephrology. Kidney Int Costa E Silva VT, Kanduri SR, Van Doren L, Lee AI, Anand S, Amarapurkar P, Benoit SW, Klomjit N, Barbir EB, Shirali AC, Bassil C, Herrmann SM, Kitchlu A, Motwani SS. PMID: 42933492 [PubMed - as supplied by publisher]
	Postoperative radiotherapy after radical cystectomy for muscle-invasive bladder cancer: Patient selection, target delineation and contemporary evidence. Cancer Radiother Huck C, Zobouyan C, Pignot G, Marcq G, Roumiguie M, Pasquier D, Achkar S, Khalifa J, Sargos P. PMID: 42933265 [PubMed - as supplied by publisher]
	Quality of life after trimodal treatment for muscle-invasive bladder cancer. Cancer Radiother Huck C, Pignot G, Masson-Lecomte A, Pasquier D, Achard V. PMID: 42933261 [PubMed - as supplied by publisher]
	Reirradiation for prostate cancer local recurrence: State of the art and future directions. Cancer Radiother Putzu C, Marinkovic M, Grujic M, Vincini MG, Zerini D, Mastroleo F, Mazzola GC, Lorubbio C, Clobiaco S, Amin K, Musi G, Mistretta FA, Luzzago S, Pasquier D, Marvaso G, Jereczek-Fossa BA. PMID: 42933257 [PubMed - as supplied by publisher]
	Online adaptive radiotherapy for prostate cancer: Current evidence and clinical perspectives. Cancer Radiother Leblanc J, Terlizzi M, Lapierre A, Le Guévelou J. PMID: 42933254 [PubMed - as supplied by publisher]
	Cost-effectiveness of capivasertib plus abiraterone for PTEN-deficient metastatic hormone-sensitive prostate cancer in the United States. PLoS One Weiss GJ. PMID: 42932296 [PubMed - indexed for MEDLINE]
	Patient-Derived Organoids for Predicting Chemotherapy Response in Bladder Cancer: A Multicenter, Real-world Validation Study. Ann Surg Oncol Zhao Y, Zhang S, Wang Y, Shen Z, Feng J, Zou J, Hou J, Zhang X, Zhou Z, Yu N, Qu S, Chen J. PMID: 42932116 [PubMed - as supplied by publisher]
	[Bilateral serous chorioretinopathy under immune checkpoint treatment- : Diagnostic dilemma in possible bilateral diffuse uveal melanocytic proliferation (BDUMP) in lymphatic metastasized chromophobe renal cell carcinoma]. Ophthalmologie Senkulak T, Böker T, Aretz T. PMID: 42931923 [PubMed - as supplied by publisher]
	A dual signal amplification photothermal biosensor based on Sn-CDs/NPC and DNA walker for prostate cancer cell detection. Mikrochim Acta Zhang S, Li R, Tan H, Hao T, Wang S, Hu Y, Guo Z, Zhang Q. PMID: 42931874 [PubMed - indexed for MEDLINE]
	Human Papillomavirus and Prostate Cancer: A Controversial Association. Pathogens Sá S, Sousa M, Pereira AC, Baylina P, Cerqueira F. PMID: 42931222 [PubMed - indexed for MEDLINE]
	Preoperative Advanced Lung Cancer Inflammation Index and Acute Kidney Injury After Adult Cardiac Surgery: A Retrospective Cohort Study. J Cardiovasc Dev Dis Gan H, Zhang R, Fan R, Yin L, Ning S, Wang J, Liu D, Chen W, Chen X, Qiu Z. PMID: 42930886 [PubMed]
	From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors-A Systematic Review. Med Sci (Basel) Cutitaru AB, Caruntu ID, Balan RA, Solcan C, Amalinei C. PMID: 42930552 [PubMed - indexed for MEDLINE]
	[(177)Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing. Curr Oncol Buonerba C, Di Lorenzo G. PMID: 42930191 [PubMed - indexed for MEDLINE]
	Immune Checkpoint Inhibitor-Associated Pneumonitis in Patients Treated for Metastatic Renal Cell Carcinoma. Curr Oncol Masur J, Mullapudi A, Ali S, Fortune K, Bueno J, Battey T, Goudarzi A, Patel H, Sturek J, Devitt M, Skelton WP 4th, Dreicer R, Viscuse P. PMID: 42930183 [PubMed - indexed for MEDLINE]
	Interpretable Machine Learning Prognostic Model Integrating Inflammatory-Nutritional Biomarkers for Post-Prostatectomy Biochemical Recurrence: Development, Internal Validation, and Translational Target Exploration. Curr Oncol Wang H, Zhang Y, Li Z, Wu J, Cao H, Gan L, Qiu X, Wang W. PMID: 42930175 [PubMed - indexed for MEDLINE]
	Exercise During Active Surveillance for Localized Low-Risk Prostate Cancer: Current Evidence and a Survivorship Framework. Curr Oncol Miller JA. PMID: 42930166 [PubMed - indexed for MEDLINE]
	Patient Journey and Treatment Patterns of Non-Muscle-Invasive Bladder Cancer in Mexico. Curr Oncol Scavuzzo A, Castillejos-Molina RA, Bravo-Castro I, Jiménez-Ríos MA, Campos-Salcedo JG, Jiménez-Dávila MA, Suaste-Carmona B, Flores-García LE, Ferreira D, Castillo V, Lugo-Martínez G, Rodríguez Covarrubias FT. PMID: 42930164 [PubMed - indexed for MEDLINE]
	Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer. N Engl J Med Powles T, Grande E, Simone G, Gómez de Liaño A, Maruzzo M, Velho PI, Kikuchi E, Vu TQ, Popovic L, Çil T, Gravis G, Radkowski R, Hernández LRN, Cutuli HJ, Bamias A, Bauernhofer T, Pavic M, Choi YJ, Chang CH, Kitamura H, Rosenberg JE, Rowbottom J, Ho S, Gupta A, Drakaki A, VOLGA Investigators. PMID: 42929692 [PubMed - as supplied by publisher]

Articles 1 - 20 / 182470

Page 1 of 9124



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy